We study the effects of firm-level exposure to an epidemic disease on corporate cash holdings amongst U.S firms. Using a text-based measure diseases and difference-in-difference estimation strategy, we document positive relationship between onset holdings. find that, all recent epidemics, COVID-19 has strongest impact that this effect is mostly driven by negative sentiments around pandemic.
